Exelixis (EXEL) Assets Average (2011 - 2026)
Exelixis (EXEL) recorded quarterly Assets Average of $2.7 billion in Q2 2026, down 4.06% quarter-over-quarter from $2.8 billion in Q1 2026, and down 6.0% on a YoY basis from $2.9 billion in Q2 2025.
Exelixis (EXEL) Assets Average (2011 - 2026) Analysis & Trends
Exelixis' Assets Average history runs 16 years deep, the most recent figure standing at $2.7 billion for Q2 2026.
- In Q2 2026, Assets Average fell 6.0% year-over-year to $2.7 billion; the TTM figure through Apr 2026 stood at $2.7 billion (down 6.0% YoY), while the FY2026 annual figure was $2.9 billion, down 1.66% from the prior year.
- Assets Average was $2.7 billion for Q2 2026 at Exelixis, down from $2.8 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $3.1 billion in Q2 2023 to a low of $2.6 billion in Q2 2022.
- Historically, Assets Average has averaged $2.9 billion across 5 years, with a median of $2.9 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average increased 21.78% in 2022, then dropped 11.28% in 2024.
- A 5-year view of Assets Average shows it stood at $3.0 billion in 2022, then decreased by 1.88% to $3.0 billion in 2023, then declined by 3.14% to $2.9 billion in 2024, then fell by 4.04% to $2.8 billion in 2025, then fell by 1.16% to $2.7 billion in 2026.
- The last three Assets Average figures came in at $2.7 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 2.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.72 Bn |
| Jan 2, 2026 | 2.83 Bn |
| Oct 3, 2025 | 2.75 Bn |
| Jul 4, 2025 | 2.76 Bn |
| Apr 4, 2025 | 2.89 Bn |
| Jan 3, 2025 | 2.95 Bn |
| Sep 27, 2024 | 2.87 Bn |
| Jun 28, 2024 | 2.79 Bn |
| Mar 29, 2024 | 2.87 Bn |
| Dec 29, 2023 | 2.96 Bn |
| Sep 29, 2023 | 3.06 Bn |
| Jun 30, 2023 | 3.14 Bn |
| Mar 31, 2023 | 3.11 Bn |
| Dec 30, 2022 | 3.02 Bn |
| Sep 30, 2022 | 2.92 Bn |
| Jul 1, 2022 | 2.77 Bn |
| Apr 1, 2022 | 2.64 Bn |
| Dec 31, 2021 | 2.53 Bn |
| Oct 1, 2021 | 2.41 Bn |
| Jul 2, 2021 | 2.28 Bn |